Skip to content

H2020FP7

Institut de Recherches Internationales Servier

Country
FRFrance
Defence projects
0
Projects, all programmes
20
As coordinator
0
EU contribution (CORDIS)
EUR 310,500
Active
2010 to 2021

Projects

20 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
T2EVOLVEAccelerating Development and Improving Access to CAR and TCR-engineered T cell therapyH20202021ParticipantEUR 0
PREMIERPrioritisation and Risk Evaluation of Medicines in the EnviRonmentH20202020ParticipantEUR 0
EU-PEARLEU Patient- cEntric clinicAl tRial pLatformH20202019ParticipantEUR 0
NECESSITYNEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patientsH20202019ParticipantEUR 0
PARADIGMPatients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.H20202018ParticipantEUR 0
DO-ITBig Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055H20202017ParticipantEUR 0
TransQSTTranslational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030H20202017ParticipantEUR 0
eTRANSAFEEnhacing TRANslational SAFEty Assessment through Integrative Knowledge ManagementH20202017ParticipantEUR 0
INSISTIN-Silico trials for treatment of acute Ischemic STrokeH20202017ParticipantEUR 85,500
BigData HeartBig Data 4 Better Hearts - Sofia ref.: 116074H20202017ParticipantEUR 0
REPROGRAMTargeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other chronic inflammatory diseasesH20202016ParticipantEUR 225,000
APPROACHApplied Public-Private Research enabling OsteoArthritis Clinical HeadwayFP72015ParticipantNot stated
ADAPT-SMARTAccelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890H20202015ParticipantEUR 0
PRECISESADSMolecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune DiseasesFP72014ParticipantNot stated
SPRINTTSarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategiesFP72014ParticipantNot stated
EMIFEuropean Medical Information FrameworkFP72013ParticipantNot stated
DIRECTDIabetes REsearCh on patient sTratificationFP72012ParticipantNot stated
MIP-DILIMechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver InjuryFP72012ParticipantNot stated
DDMOREDrug Disease Model ResourcesFP72011ParticipantNot stated
ETOXIntegrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicitiesFP72010ParticipantNot stated

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.